AG
PMC

Aperio Group’s PharMerica Corporation PMC Stock Holding History

Aperio Group’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,100
Closed -$267K – 2275
2017
Q3 		$267K Buy
9,100
+1,152
+14% +$32.3K ﹤0.01% 1982
2017
Q2 		$209K Buy
+7,948
New +$195K ﹤0.01% 2081
2017
Q1 		– Sell
-8,804
Closed -$221K – 2193
2016
Q4 		$221K Sell
8,804
-1,006
-10% -$25.4K ﹤0.01% 1953
2016
Q3 		$275K Buy
+9,810
New +$251K ﹤0.01% 1762
2016
Q1 		– Sell
-9,352
Closed -$327K – 2094
2015
Q4 		$327K Buy
9,352
+1,710
+22% +$53.6K ﹤0.01% 1563
2015
Q3 		$218K Buy
7,642
+239
+3% +$8.03K ﹤0.01% 1727
2015
Q2 		$247K Buy
7,403
+166
+2% +$5.1K ﹤0.01% 1753
2015
Q1 		$204K Buy
+7,237
New +$180K ﹤0.01% 1821

Aperio Group's PMC Position: Q4 2017 in Review

Aperio Group sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 9,100 shares — an estimated $267K sold.

Aperio Group first reported a position in PMC in Q1 2015 and held it in 8 quarters. The position peaked at $327K in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Aperio Group reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Aperio Group sold 9,100 PharMerica Corporation shares in Q4 2017, an estimated $267K.
  • Aperio Group first reported a position in PharMerica Corporation in Q1 2015 and held it in 8 quarters.
  • Aperio Group's PharMerica Corporation position peaked at $327K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Aperio Group's 13F filing for Q4 2017, filed 2 Feb 2018.